Insider · CIK 0001518734
George Cardoza
Files at SOPH (SOPHiA GENETICS SA). First filing Mar 20, 2026, latest Oct 7, 2026.
In brief
George Cardoza files SEC Form 4 as CFO at SOPH (SOPHiA GENETICS SA). Since Mar 20, 2026, George Cardoza has reported 1 open-market buy worth $99k and 7 open-market sells worth $66k, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; George Cardoza has 0, so none is measured yet.
The newest scored trade: sold $13k of SOPH on Oct 5, 2026, filed Oct 7, 2026, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 1 buy worth $99k and 7 sells worth $66k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SOPH: SOPHiA GENETICS SA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | SOPHiA GENETICS SA | $13k 1,592 shares | -1% | +111% from low-8% from high | |
| 17Weak | SOPHiA GENETICS SA | $6,447 774 shares | -0% | +140% from low-8% from high | |
| 17Weak | SOPHiA GENETICS SA | $8,419 1,592 shares | -1% | +77% from low-11% from high | |
| 17Weak | SOPHiA GENETICS SA | $4,164 774 shares | -0% | +79% from low-3% from high | |
| 35Weak | SOPHbuy SOPHiA GENETICS SA | $99k 20,000 shares | +7% | +75% from low-9% from high | |
| 17Weak | SOPHiA GENETICS SA | $6,801 1,403 shares | -0% | +83% from low-12% from high | |
| 17Weak | SOPHiA GENETICS SA | $24k 4,933 shares | -2% | +86% from low-10% from high | |
| 17Weak | SOPHiA GENETICS SA | $3,705 774 shares | -0% | +83% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHIA GENETICS SA | 1,592 0.00% of outstanding | $13k | Oct 5, 2026 | $15k |
| Sep 21, 2026 | SOPH SOPHIA GENETICS SA | 774 0.00% of outstanding | $6,339 | Sep 21, 2026 | $13k |
| Jul 6, 2026 | SOPH SOPHIA GENETICS SA | 1,592 0.00% of outstanding | $8,517 | Jul 6, 2026 | $23k |
| Jun 22, 2026 | SOPH SOPHIA GENETICS SA | 774 0.00% of outstanding | $4,226 | Jun 22, 2026 | $31k |
| Apr 8, 2026 | SOPH SOPHIA GENETICS SA | 1 0.00% of outstanding | $5 | Apr 8, 2026 | $28k |
| Apr 6, 2026 | SOPH SOPHIA GENETICS SA | 6,335 0.01% of outstanding | $32k | Apr 6, 2026 | $3,705 |
| Mar 19, 2026 | SOPH SOPHIA GENETICS SA | 774 0.00% of outstanding | $3,800 | Mar 19, 2026 | $4,065 |
| Dec 19, 2025 | SOPH SOPHIA GENETICS SA | 3,441 0.01% of outstanding | $16k | Dec 19, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,592 | $8.10 | $13k | 306,726 | 8 d ago |
| Sep 21, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -774 | $8.33 | $6,447 | 308,318 | 23 d ago |
| Jul 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,592 | $5.29 | $8,419 | 309,092 | Jul 7, 2026 |
| Jun 22, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -774 | $5.38 | $4,164 | 310,684 | Jun 23, 2026 |
| Jun 5, 2026 | SOPH SOPHiA GENETICS SA | POpen-market purchase Ordinary Shares | +20,000 | $4.95 | $99k | 311,458 | Jun 5, 2026 |
| Apr 8, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,403 | $4.85 | $6,801 | 291,458 | Apr 10, 2026 |
| Apr 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,520 | $4.85 | $12k | 295,274 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +112,936 | $0.00 | $0 | 297,794 | Apr 8, 2026 |
| Apr 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,413 | $4.88 | $12k | 292,861 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +164,671 | $0.00 | $0 | 164,671 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +112,936 | $0.00 | $0 | 112,936 | Apr 3, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +164,671 | $0.00 | $0 | 164,671 | Apr 3, 2026 |
| Mar 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -774 | $4.79 | $3,705 | 184,858 | Mar 20, 2026 |
Questions about George Cardoza
Answered from the filings on this page, as of the latest one.
Is George Cardoza buying or selling?
In the last 12 months George Cardoza reported 1 open-market buy worth $99k and 7 open-market sells worth $66k on SEC Form 4; the latest was sold $13k of SOPH on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did George Cardoza's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and George Cardoza has 0.
Where does George Cardoza file Form 4?
George Cardoza has filed Form 4 at SOPH (SOPHiA GENETICS SA) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.